Study of lemborexant for nighttime urination in older adults
Treatments studied
Part of Kidney & urinary clinical trials.
This study tests a sleep medication, lemborexant, to see if it helps reduce the number of times older adults wake up at night to urinate. It may improve sleep quality and reduce bother from nighttime urination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You wake up at night to urinate and find it bothersome (score 4 or more on a scale).
- You have tried simple measures like reducing fluids before bed and elevating your legs for 4 weeks, but still have bothersome nighttime urination.
- If you take medication for overactive bladder, you must be on a stable dose for at least 12 weeks.
- You are willing to avoid alcohol during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a behavioral sleep program plus brief mindfulness exercises can reduce how often older women wake up at night to urinate. It may improve sleep quality and reduce nighttime bathroom trips.
This study looks at whether two different bladder medications can help reduce nighttime bathroom trips and urine leaks in women with urgency incontinence. It aims to find out which treatment works better to improve sleep and quality of life.
This study aims to improve nighttime urination (nocturia) and sleep in adults 60 and older. It offers a program that combines behavioral techniques for both bladder control and insomnia, with weekly visits at an Atlanta VA clinic.
This study tests if lemborexant, a sleep medication, can help people with both a mental health condition and insomnia. You would take the medicine as prescribed and complete questionnaires over 2 months.
This study is testing whether a sleep medication called lemborexant can improve sleep and reduce Alzheimer's-related proteins in healthy older adults with no memory problems. It could help find new ways to delay or prevent Alzheimer's disease.
This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.
Hear when a new Nocturia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.